Translate
Glucotrack Inc
About
Glucotrack Inc (NASDAQ:GCTK) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Glucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology
Mar 30 2026
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Mar 27 2026
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones
Mar 10 2026
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit
Jan 29 2026
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
Financials
Revenue
$0
Market Cap
$839.56 K
EPS
-31.22